on 04 Sep 2018
Last Applicant/ Owned by
Biocity Scotland, Bo'Ness Road
Newhouse-N Lanarkshire
ML15UH
Serial Number
87534461 filed on 19th Jul 2017
Registration Number
5553177 registered on 04th Sep 2018
Correspondent Address
David L. Rein Jr.
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Scientific and technological services, namely, research and design in the field of pharmaceutical preparations for the treatment of degenerative kidney diseases, rare diseases, chronic inflammatory diseases and cancer; pharmaceutical research services; scientific research Pharmaceutical preparations for the treatment of degenerative kidney diseases, rare diseases, chronic inflammatory diseases an Read More
Scientific and technological services, namely, research and design in the field of pharmaceutical preparations for the treatment of degenerative kidney diseases, rare diseases, chronic inflammatory diseases and cancer; pharmaceutical research services; scientific research
Pharmaceutical preparations for the treatment of degenerative kidney diseases, rare diseases, chronic inflammatory diseases and cancer; veterinary preparations and substances for the treatment of degenerative kidney diseases, rare diseases, chronic inflammatory diseases and cancer; pharmaceutical preparations and substances for the treatment of degenerative kidney diseases, rare diseases, chronic inflammatory diseases and cancer
No 87534461
No Service Mark
No 5016.001
No
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
04th Sep 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
04th Sep 2018 | REGISTERED-PRINCIPAL REGISTER |
19th Jun 2018 | PUBLISHED FOR OPPOSITION |
19th Jun 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
30th May 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
17th May 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
24th Apr 2018 | ASSIGNED TO LIE |
24th Apr 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
24th Apr 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
17th Apr 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |